Insufficient scRNA-seq data for expression of PNLDC1 at single-cell level.
Insufficient scRNA-seq data for expression of PNLDC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 91% | 53.56 | 297 / 328 | 27% | 0.74 | 48 / 178 |
brain | 86% | 128.95 | 2280 / 2642 | 17% | 0.46 | 119 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.19 | 1 / 1 |
breast | 58% | 52.70 | 268 / 459 | 19% | 2.61 | 212 / 1118 |
esophagus | 49% | 26.81 | 714 / 1445 | 25% | 3.35 | 45 / 183 |
bladder | 62% | 28.95 | 13 / 21 | 7% | 1.28 | 37 / 504 |
spleen | 66% | 46.83 | 160 / 241 | 0% | 0 | 0 / 0 |
intestine | 57% | 27.65 | 555 / 966 | 6% | 0.39 | 31 / 527 |
ovary | 47% | 47.73 | 84 / 180 | 16% | 1.24 | 69 / 430 |
uterus | 42% | 23.49 | 71 / 170 | 21% | 7.25 | 95 / 459 |
prostate | 57% | 40.85 | 140 / 245 | 3% | 0.16 | 15 / 502 |
lung | 42% | 31.75 | 242 / 578 | 17% | 3.82 | 199 / 1155 |
skin | 46% | 76.89 | 831 / 1809 | 12% | 4.89 | 55 / 472 |
stomach | 43% | 20.34 | 154 / 359 | 7% | 0.42 | 20 / 286 |
blood vessel | 47% | 21.78 | 631 / 1335 | 0% | 0 | 0 / 0 |
kidney | 42% | 21.20 | 37 / 89 | 4% | 0.33 | 33 / 901 |
liver | 40% | 40.04 | 90 / 226 | 3% | 0.29 | 11 / 406 |
thymus | 36% | 29.17 | 235 / 653 | 6% | 0.71 | 35 / 605 |
adrenal gland | 28% | 31.07 | 71 / 258 | 7% | 0.20 | 16 / 230 |
adipose | 34% | 22.28 | 405 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 12.82 | 14 / 45 |
heart | 26% | 16.16 | 220 / 861 | 0% | 0 | 0 / 0 |
muscle | 20% | 7.83 | 159 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 18% | 16.30 | 170 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.19 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000289 | Biological process | nuclear-transcribed mRNA poly(A) tail shortening |
GO_0034587 | Biological process | piRNA processing |
GO_1990432 | Biological process | siRNA 3'-end processing |
GO_0007283 | Biological process | spermatogenesis |
GO_0001825 | Biological process | blastocyst formation |
GO_1990431 | Biological process | priRNA 3'-end processing |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005634 | Cellular component | nucleus |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0004535 | Molecular function | poly(A)-specific ribonuclease activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PNLDC1 |
Protein name | PARN like ribonuclease domain containing exonuclease 1 Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1) (HsPNLDC1) |
Synonyms | |
Description | FUNCTION: 3'-exoribonuclease that has a preference for poly(A) tails of mRNAs, thereby efficiently degrading poly(A) tails . Exonucleolytic degradation of the poly(A) tail is often the first step in the decay of eukaryotic mRNAs and is also used to silence certain maternal mRNAs translationally during oocyte maturation and early embryonic development . May act as a regulator of multipotency in embryonic stem cells (By similarity). Is a critical factor for proper spermatogenesis, involved in pre-piRNAs processing to generate mature piRNAs . . |
Accessions | ENST00000610273.5 [Q8NA58-1] ENST00000610041.5 ENST00000392167.4 [Q8NA58-2] ENST00000275275.9 V9GYA0 Q8NA58 ENST00000610048.5 |